Literature DB >> 8830480

Impairment of bone marrow pre-B and B cells in MHV3 chronically-infected mice.

P Jolicoeur1, L Lamontagne.   

Abstract

Mouse hepatitis virus type 3 (MHV3) appears to be an excellent model for the study of the relationship between viral-induced immunodeficiency and the development of chronic disease. Animal surviving acute hepatitis develop a chronic disease characterized by viral persistency in various organs, by a humoral immunodeficiency, and eventually die within the next three months postinfection. To verify if B cell immunodeficiency occurs during the chronic disease, percentage and absolute number of bone marrow B lineage cell subpopulations were recorded at various times postinfection (p.i.) in pathogenic L2-MHV3-infected (C57BL/6 x A/J) F1 mice. Absolute numbers of B (cmu+smu+) cells decreased as early as three days p.i. up to 15 days p.i., and then gradually returned toward normal values in L2-MHV3-infected mice during the chronic disease. In contrast, pre-B (cmu+smu-) cells were less significantly decrease during the chronic disease. In addition, abnormally enlarged cells (> 13 microns) were detected either in bone marrow pre-B or B cells from L2-MHV3-infected mice.

Entities:  

Mesh:

Year:  1995        PMID: 8830480     DOI: 10.1007/978-1-4615-1899-0_33

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

Review 1.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Thrombocytopenia in the Course of COVID-19 Infection.

Authors:  Noel Lorenzo-Villalba; Abrar-Ahmad Zulfiqar; Marc Auburtin; Marie Helene Schuhmacher; Alain Meyer; Yasmine Maouche; Olivier Keller; Emmanuel Andres
Journal:  Eur J Case Rep Intern Med       Date:  2020-05-07

Review 3.  Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research.

Authors:  Enrico Radaelli; Sara F Santagostino; Rani S Sellers; Cory F Brayton
Journal:  ILAR J       Date:  2018-12-31

4.  Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship with Disease Prognosis.

Authors:  Mohammad Eslamijouybari; Keyvan Heydari; Iradj Maleki; Mahmood Moosazadeh; Akbar Hedayatizadeh-Omran; Lale Vahedi; Roya Ghasemian; Ali Sharifpour; Reza Alizadeh-Navaei
Journal:  Caspian J Intern Med       Date:  2020

5.  Clinical features and viral RNA shedding of imported and local cases with COVID-19 in Wenzhou, China.

Authors:  Guiqing He; Jing Wu; Jianping Huang; John S Schieffelin; Jianyi Dai; Michelle Gamber; Xingzhong Hu; Quelu Chen; Yang Si; Wenjie Sun; Jing Cai
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

Review 6.  Impact of SARS-CoV-2 on the clinical outcomes and placental pathology of pregnant women and their infants: A systematic review.

Authors:  Irina Oltean; Jason Tran; Sarah Lawrence; Brittany Ann Ruschkowski; Na Zeng; Cameron Bardwell; Youssef Nasr; Joseph de Nanassy; Dina El Demellawy
Journal:  Heliyon       Date:  2021-03-02

7.  Isolated severe thrombocytopenia in a patient with COVID-19: A case report.

Authors:  Sara Sadr; SeyedAhmad SeyedAlinaghi; Fereshteh Ghiasvand; Malihe Hassan Nezhad; Nina Javadian; Roghieh Hossienzade; Fatemeh Jafari
Journal:  IDCases       Date:  2020-05-29

8.  Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.

Authors:  Giuseppe Lippi; Mario Plebani; Brandon Michael Henry
Journal:  Clin Chim Acta       Date:  2020-03-13       Impact factor: 3.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.